NCT02088866View on ClinicalTrials.gov

Commercial Lidocaine Patch as a Treatment for Ear-ringing

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Tinnitus
Interventions
DRUG

Transdermal Lidocaine

The intervention will use 5% commercially available transdermal lidocaine in clinical practice for the treatment of tinnitus. This dose will be tailored to patient preference.

Trial Locations (1)

95817

UC Davis Department of Otolaryngology, Sacramento

All Listed Sponsors
lead

University of California, Davis

OTHER

NCT02088866 - Commercial Lidocaine Patch as a Treatment for Ear-ringing | Biotech Hunter | Biotech Hunter